What is Global Bare Metal Stents Market?
The Global Bare Metal Stents Market is a fascinating and complex sector of the healthcare industry. Bare Metal Stents, or BMS, are tiny wire mesh tubes used to open up blocked coronary arteries, allowing blood to flow freely to the heart. These stents are called "bare" because they do not have a drug coating, unlike drug-eluting stents. The global market for these devices was valued at a substantial US$ 606 million in 2022. This figure is expected to rise to US$ 726.8 million by 2029, indicating a Compound Annual Growth Rate (CAGR) of 2.6% from 2023 to 2029. This growth is a testament to the increasing demand for these devices worldwide.
Co-Cr Stent, Pt-Cr Stent, Others in the Global Bare Metal Stents Market:
The Bare Metal Stents market is dominated by four major manufacturers, who collectively hold over 70% of the market share. This indicates a high level of consolidation in the market, with these key players dictating the trends and dynamics of the sector.
For Large Vessel (Greater Than or Equal 3mm), For Small Vessel (Less Than 3mm) in the Global Bare Metal Stents Market:
In terms of product types within the Bare Metal Stents market, the Co-Cr Stent is the most popular, accounting for nearly 80% of the market. Co-Cr Stents, or Cobalt-Chromium Stents, are made from a high-performance alloy that combines the strength of cobalt and the corrosion resistance of chromium. These stents are favored for their durability and biocompatibility.
Global Bare Metal Stents Market Outlook:
The Bare Metal Stents market also includes Pt-Cr Stents, or Platinum-Chromium Stents. These stents are made from a different alloy that offers a unique combination of strength, flexibility, and visibility. While not as popular as Co-Cr Stents, Pt-Cr Stents still hold a significant share of the market. The market also includes other types of stents, although data on these is not readily available.
| Report Metric | Details |
| Report Name | Bare Metal Stents Market |
| Accounted market size in 2022 | US$ 606 in million |
| Forecasted market size in 2029 | US$ 726.8 million |
| CAGR | 2.6% |
| Base Year | 2022 |
| Forecasted years | 2023 - 2029 |
| Segment by Type |
|
| Segment by Application |
|
| Consumption by Region |
|
| By Company | Abbott Vascular, Medtronic, Boston Scientific, Terumo, Biosensors, B.Braun, MicroPort, Biotronik |
| Forecast units | USD million in value |
| Report coverage | Revenue and volume forecast, company share, competitive landscape, growth factors and trends |
